We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

bioMérieux

Designs, develops, manufactures and markets in vitro diagnostics systems used in clinical and industrial applications read more Featured Products: More products

Download Mobile App




Innovative ID/AST System to Help Diagnose Infectious Diseases and Combat AMR

By LabMedica International staff writers
Posted on 20 Mar 2025

Each year, 11 million people across the world die of sepsis out of which 1. More...

3 million deaths are due to antibiotic-resistant bacteria. The burden of antimicrobial resistance (AMR) continues to weigh heavily, complicating the detection of resistant pathogens. There is a need for clinicians to get accurate identification and faster antibiotic susceptibility test (AST) results, thereby enabling timely and appropriate patient intervention. Now, an innovative system for microorganism identification (ID) and antibiotic susceptibility testing (AST) can benefit clinical laboratories to help diagnose infectious diseases and combat AMR.

bioMérieux’s (Marcy l'Etoile, France) VITEK® COMPACT PRO combines the latest diagnostic technology with the globally acknowledged advantages of its predecessor: VITEK® 2 COMPACT. With an ergonomically advanced design and a simplified workflow, it further enhances the user experience and improves overall efficiency as the laboratory technician has to spend less time for sample loading and processing. It offers one of the most efficient workflows, fastest routine ID/AST results and microbiology expertise for accurate and confident diagnostics insights.

Ideally suited for small and medium-sized laboratories, VITEK® COMPACT PRO also enables laboratories transitioning from manual workflows to benefit from automation efficiencies. bioMérieux has now received U.S. Food and Drug Administration (FDA) 510(k) clearance for VITEK® COMPACT PRO. The commercial launch of VITEK® COMPACT PRO is initially planned in select countries, followed by a global launch starting in the second quarter of 2025.

"For decades, bioMérieux has been an industry leader in microbiology innovation. With the introduction of VITEK® COMPACT PRO, we are continuing this journey and delivering on the specialized needs of our customers – supporting laboratories with simplified, efficient workflows and the latest technology to optimize their experience," said Jennifer Zinn, Executive Vice President, Clinical Operations. “Through ongoing expansion of our VITEK® solutions portfolio, bioMérieux continues to strengthen our comprehensive AMR/AMS offer and reinforce our commitment to provide next-generation ID/AST systems to healthcare and laboratory professionals around the world.”

"As a leader in the fight against AMR, bioMérieux continuously innovates by developing and renewing its key diagnostic solutions," added Céline Roger-Dalbert, Executive Vice President, Research and Development. “VITEK® COMPACT PRO delivers fast, accurate and reproducible results comparable to VITEK® 2 and VITEK® 2 COMPACT systems. The ergonomic features, a new intuitive user interface, and an updated software with one of the most comprehensive knowledge database makes VITEK® COMPACT PRO highly appealing to both clinical and industrial laboratories.”


Gold Member
Immunochromatographic Assay
CRYPTO Cassette
New
Gold Member
Ketosis and DKA Test
D-3-Hydroxybutyrate (Ranbut) Assay
New
Gold Member
Automatic CLIA Analyzer
Shine i9000
6 Part Hematology Analyzer with RET + IPF
Mispa HX 88
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: Sickle cell disease patients with higher levels of RMVs, AMVs, and EMVs were found to have more severe disease (Photo courtesy of Adobe Stock)

Microvesicles Measurement Could Detect Vascular Injury in Sickle Cell Disease Patients

Assessing disease severity in sickle cell disease (SCD) remains challenging, especially when trying to predict hemolysis, vascular injury, and risk of complications such as vaso-occlusive crises.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.